Cargando…

Visceral Adiposity Index: Simple Tool for Assessing Cardiometabolic Risk in Women with Polycystic Ovary Syndrome

AIM: To study visceral adiposity index (VAI) and its association with cardiometabolic risk in different phenotypes of polycystic ovary syndrome (PCOS). MATERIALS AND METHODS: It is a case–control cross-sectional study where 100 reproductive age (18–35 years) women with PCOS were classified in differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agrawal, Hiya, Aggarwal, Kiran, Jain, Anju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540888/ https://www.ncbi.nlm.nih.gov/pubmed/31161109 http://dx.doi.org/10.4103/ijem.IJEM_559_18

Ejemplares similares

Indirect Predictors of Visceral Adipose Tissue in Women with Polycystic Ovary Syndrome: A Comparison of Methods
por: Kałużna, Małgorzata, et al.
Publicado: (2021)

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

Visceral Adiposity Index and Lipid Accumulation Product as diagnostic markers of Metabolic Syndrome in South Indians with Polycystic Ovary Syndrome
por: Naghshband, Zeinab, et al.
Publicado: (2021)

The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome
por: Wang, Haiyan, et al.
Publicado: (2023)

Lipid Accumulation Product Better Predicts Metabolic Status in Lean Polycystic Ovary Syndrome than that by Visceral Adiposity Index
por: Banu, Hurjahan, et al.
Publicado: (2022)

The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2020)

Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk
por: Amato, Marco C., et al.
Publicado: (2010)

The Association Between Serum Ferritin Concentration and Visceral Adiposity Estimated by Whole-Body DXA Scan in Women With Polycystic Ovary Syndrome
por: Adamska, Agnieszka, et al.
Publicado: (2020)

Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome
por: Kabakchieva, Plamena, et al.
Publicado: (2022)

Cardiometabolic Index (CMI) and Visceral Adiposity Index (VAI) Highlight a Higher Risk of Metabolic Syndrome in Women with Severe Obesity
por: Lazzer, Stefano, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women
por: Baldani, Dinka Pavicic, et al.
Publicado: (2015)

Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2021)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome
por: Çakır Biçer, Nihan, et al.
Publicado: (2023)

Study of Visceral and Subcutaneous Abdominal Fat Thickness and Its Correlation with Cardiometabolic Risk Factors and Hormonal Parameters in Polycystic Ovary Syndrome
por: Jena, Debarchan, et al.
Publicado: (2018)

The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome
por: Arpaci, Dilek, et al.
Publicado: (2015)

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
por: Torres Fernandez, Edgar D, et al.
Publicado: (2018)

Epicardial adipose tissue thickness and NGAL levels in women with polycystic ovary syndrome
por: Sahin, Serap Baydur, et al.
Publicado: (2014)

Visceral Adiposity Index as an Indicator for Menstrual Disturbance, Hormonal and Metabolic Dysfunction in Polycystic Ovarian Syndrome
por: Sharma, Priyanka, et al.
Publicado: (2022)

The Role of C-Peptide as Marker of Cardiometabolic Risk in Women With Polycystic Ovary Syndrome: A Controlled Study
por: de Medeiros, Sebastiao Freitas, et al.
Publicado: (2018)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

Derivation and validation of a new visceral adiposity index for predicting visceral obesity and cardiometabolic risk in a Korean population
por: Oh, Sung-Kwan, et al.
Publicado: (2018)

Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome
por: Scott, David, et al.
Publicado: (2016)

Neural networks applied to 12-lead electrocardiograms predict body mass index, visceral adiposity and concurrent cardiometabolic ill-health
por: Li, Xinyang, et al.
Publicado: (2021)

Clinical characteristics of polycystic ovary syndrome in Indian women
por: Ramanand, Sunita J., et al.
Publicado: (2013)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

Differences in metabonomic profiles of abdominal subcutaneous adipose tissue in women with polycystic ovary syndrome
por: Di, Fangfang, et al.
Publicado: (2023)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Clinical management of pregnancy in women with polycystic ovary syndrome: An expert opinion
por: Bahri Khomami, Mahnaz, et al.
Publicado: (2022)

Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population
por: Amato, Marco C, et al.
Publicado: (2011)

Polycystic Ovary Syndrome: An Apparently Simple yet Challenging Diagnosis
por: Ramezani Tehrani, Fahimeh
Publicado: (2015)

The Effect of Exercise on Cardiometabolic Risk Factors in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Breyley-Smith, Annabelle, et al.
Publicado: (2022)

Thyroid Hormones and Cardiometabolic Risk Factors in Saudi Women with Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Saeed, Walaa Mohammed, et al.
Publicado: (2023)

Leptin and body mass index in polycystic ovary syndrome
por: Jalilian, Nasrin, et al.
Publicado: (2016)

Renal resistive index in patients with polycystic ovary syndrome
por: Tüfekçioğlu, Gülsen, et al.
Publicado: (2019)

Can Visceral Adiposity Index Serve as a Simple Tool for Identifying Individuals with Insulin Resistance in Daily Clinical Practice?
por: Štěpánek, Ladislav, et al.
Publicado: (2019)

AMPK Activation Is Important for the Preservation of Insulin Sensitivity in Visceral, but Not in Subcutaneous Adipose Tissue of Postnatally Overfed Rat Model of Polycystic Ovary Syndrome
por: Mićić, Bojana, et al.
Publicado: (2022)

Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS
por: Jiskoot, Geranne, et al.
Publicado: (2023)

Serum Leptin Level in Women with Polycystic Ovary Syndrome: Correlation with Adiposity, Insulin, and Circulating Testosterone
por: Chakrabarti, J
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1lfqgr1s26bs6ep3batndh94v9